Answers are grounded in this paper and cite their sources.
Cerebral autoregulation is preserved in most patients with end-stage liver disease. In patients with hepatic encephalopathy and low MAP, however, cerebral autoregulation is impaired.
No takes yet. Share an insight, caveat, or question.
都司 et al. (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: